One and Done

On February 27, 2021, the FDA issued an emergency use authorization for a one-dose SARS-CoV-2 vaccine developed by Janssen Pharmaceutica, a Belgium-based division of Johnson & Johnson.

Source: virology blog - March 4, 2021 Category: Virology Authors: Gertrud U. Rey Tags: Basic virology Gertrud Rey Uncategorized adenovirus-vectored vaccine efficacy emergency use authorization FDA furin Johnson & Johnson pre-fusion spike protein SARS-CoV-2 single dose spike glycoprotein spike glycoprotein cleavage Source Type: blogs